Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001628280-25-005686
Filing Date
2025-02-14
Accepted
2025-02-14 16:03:21
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 10152
  Complete submission text file 0001628280-25-005686.txt   11892
Mailing Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210
Business Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210 (877) 442-5362
Ginkgo Bioworks Holdings, Inc. (Subject) CIK: 0001830214 (see all company filings)

EIN.: 872652913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-92710 | Film No.: 25628143
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O SOARING EAGLE ACQUISITION CORP. 955 FIFTH AVENUE NEW YORK NY 10075
Business Address
Shetty Reshma P. (Filed by) CIK: 0001873523 (see all company filings)

Type: SCHEDULE 13D/A